SK11732003A3 - Spôsob výroby očkovacej látky - Google Patents

Spôsob výroby očkovacej látky Download PDF

Info

Publication number
SK11732003A3
SK11732003A3 SK1173-2003A SK11732003A SK11732003A3 SK 11732003 A3 SK11732003 A3 SK 11732003A3 SK 11732003 A SK11732003 A SK 11732003A SK 11732003 A3 SK11732003 A3 SK 11732003A3
Authority
SK
Slovakia
Prior art keywords
antibodies
ligands
antibody
vaccine
autologous
Prior art date
Application number
SK1173-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Gottfried Himmler
Hans Loibner
Helmut Eckert
Doblhoff-Dier
Ralf Kircheis
Manfred Schuster
Erich Wasserbauer
G�Nter Waxenecker
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag filed Critical Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag
Publication of SK11732003A3 publication Critical patent/SK11732003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1173-2003A 2001-03-23 2002-03-20 Spôsob výroby očkovacej látky SK11732003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes
PCT/AT2002/000091 WO2002080966A2 (de) 2001-03-23 2002-03-20 Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes

Publications (1)

Publication Number Publication Date
SK11732003A3 true SK11732003A3 (sk) 2004-03-02

Family

ID=3674741

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1173-2003A SK11732003A3 (sk) 2001-03-23 2002-03-20 Spôsob výroby očkovacej látky

Country Status (13)

Country Link
US (1) US20040191242A1 (hu)
EP (1) EP1370289A2 (hu)
JP (1) JP2004524369A (hu)
CN (1) CN1522155A (hu)
AT (1) AT410636B (hu)
BR (1) BR0208641A (hu)
CA (1) CA2441499A1 (hu)
HU (1) HUP0303638A3 (hu)
MX (1) MXPA03008587A (hu)
NO (1) NO20034145L (hu)
PL (1) PL363720A1 (hu)
SK (1) SK11732003A3 (hu)
WO (1) WO2002080966A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
WO2005090403A2 (en) * 2004-03-12 2005-09-29 Biovest International, Inc. Method and apparatus for antibody purification
JP5415963B2 (ja) * 2007-02-21 2014-02-12 オスロ ユニベルシテートシケヒュース ホーエフ 新しい癌マーカー
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
WO2022103871A1 (en) * 2020-11-10 2022-05-19 Wyomingv Immune, Inc. Therapeutic compositions for the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436558A1 (de) * 1994-10-13 1996-04-18 Vitorgan Arzneimittel Gmbh Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen
EP0792294A1 (en) * 1994-11-16 1997-09-03 Baxter International Inc. Human antibodies to t-cell receptor peptides and methods for their preparation
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
WO1998026086A1 (en) * 1996-12-11 1998-06-18 University Of Florida Novel methods and compositions for treatment of autoimmune diseases
US7022036B2 (en) * 2003-05-21 2006-04-04 Prototoy Llc Electronic throw-and-catch game

Also Published As

Publication number Publication date
NO20034145L (no) 2003-11-07
AT410636B (de) 2003-06-25
BR0208641A (pt) 2004-03-09
WO2002080966A2 (de) 2002-10-17
PL363720A1 (en) 2004-11-29
HUP0303638A2 (hu) 2004-01-28
CN1522155A (zh) 2004-08-18
ATA4702001A (de) 2002-11-15
HUP0303638A3 (en) 2004-10-28
CA2441499A1 (en) 2002-10-17
JP2004524369A (ja) 2004-08-12
WO2002080966A3 (de) 2003-09-12
MXPA03008587A (es) 2004-06-30
WO2002080966A8 (de) 2003-01-23
NO20034145D0 (no) 2003-09-17
US20040191242A1 (en) 2004-09-30
EP1370289A2 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
US5698679A (en) Product and process for targeting an immune response
US8444974B2 (en) Use of antibodies for the vaccination against cancer
AU780853B2 (en) Use of anti-idiotypical antibodies as vaccines against cancer
EP2089431A2 (en) Methods and compositions for efficient removal of protein a from binding molecule preparations
SK11732003A3 (sk) Spôsob výroby očkovacej látky
US7687060B2 (en) Method for the treatment or prophylaxis of tuberculosis
CZ20032573A3 (cs) Způsob výroby očkovací látky
US20060018901A1 (en) Use of antibodies in a very low dose for the vaccination against cancer
AU2002242447B2 (en) Use of polyclonal immunoglobulins
WO1990001066A1 (en) Porcine polyclonal and monoclonal antibodies
US20040265318A1 (en) Use of antibodies for the vaccination against cancer

Legal Events

Date Code Title Description
FC9A Refused patent application